Piramal Healthcare entered into pharmaceutical sector in 1988. Today Piramal’s pharmaceutical business comprises pharma solutions, critical care, consumer products and lab-diagnostics, which contributes to over 90 percent of the company’s revenues. The health care vertical of PEL is further divided into the key business divisions. It recently bought regenerative medical device BST-CarGel from BioSyntech, Canada. They also set up a new company called Piramal Imaging, when they acquired the molecular imaging arm from Bayer pharma in Berlin, Germany. The UN Conference on Trade and Development’s World Investment Report 2011 ranked Piramal Enterprises' CMO (contract manufacturing) business vertical as number five in the top 10 pharmaceutical contract manufacturers worldwide; and was awarded the number one position amongst all Indian CMOs. Piramal Enterprises announced its Q4 and annual results for FY 2012 on 3 May 2012. Total operating income for the quarter was 688.1 crores. Income from investments for the quarter was 39.1 crores and operating profit (OPBITDA) was Rs 150.0 crores.
Piramal Healthcare is listed on BSE and NSE.
Below you will find details about Piramal Life Sciences Limited Company Profile, Share Price, News, Address, Management, Registrar and Contact Details.
|
|
Freedom Registry Ltd. Plot No. 101/102,
MIDC Industrial Area,19th Street,
Satpur
Tel: 0253-2354032, 2351892, 2363372
Fax: 0253-2351126
|
